Printer Friendly
The Free Library
19,573,952 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

AVANIR Completes $17.1 Million Sale of Common Stock.


SAN DIEGO San Diego (săn dēā`gō), city (1990 pop. 1,110,549), seat of San Diego co., S Calif., on San Diego Bay; inc. 1850. San Diego includes the unincorporated communities of La Jolla and Spring Valley. Coronado is across the bay.  -- AVANIR Pharmaceuticals (AMEX AMEX

See: American Stock Exchange
:AVN AVN Aviation
AVN Avenue
AVN Adult Video News
AVN Avascular Necrosis
AVN Atrioventricular Node
AVN Aviation Model (weather forecast model, now Global Forecast System)
AVN Air Vanuatu (ICAO code) 
) announced that on April 8, 2005, it completed the previously announced sale of 7,770,000 shares of Class A common stock in a registered direct offering at a price of $2.20 per share. The offering raised gross offering proceeds of approximately $17.1 million and net offering proceeds of approximately $15.8 million, after deducting commissions and offering fees and expenses.

All of the shares were sold by AVANIR Pharmaceuticals. The shares were offered under the Company's effective shelf registration statement on Form S-3. CIBC World Markets CIBC World Markets is the investment banking division of the Canadian Imperial Bank of Commerce. It helps governments, large companies, and other large institutions obtain capital and credit and is a primary dealer in U.S. Treasury securities.  Corp. acted as sole bookrunning placement agent, and Leerink Swann & Co. acted as co-placement agent in connection with this transaction.

AVANIR Pharmaceuticals, based in San Diego, is a drug discovery and development company focused on the development of treatments for chronic diseases.

The information contained in this press release, including any forward-looking statements forward-looking statement

A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections.
 contained herein, should be reviewed in conjunction with the company's most recent Annual Report on Form 10-K Form 10-K

A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information.


Form 10-K

See 10-K.
 and other publicly available information regarding the company. Copies of such information are available from the company upon request. Such publicly available information sets forth many risks and uncertainties related to the company's business and technology. Forward-looking statements often contain such words like "estimate," "anticipate," "believe," "plan" or "expect." The Company disclaims any intent or obligation to update these forward-looking statements.
COPYRIGHT 2005 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Apr 12, 2005
Words:226
Previous Article:Ashworth Applauds Chris DiMarco at 2005 Masters.
Next Article:The Line-up is Set; Red Sox and Dunkin' Donuts Score a Double Play; Brand Signs Theo Epstein and Johnny Damon to Bring On Spring Fever in New Iced...



Related Articles
AVANIR Pharmaceuticals Reports Fourth Quarter and Fiscal 2004 Year End Results.
AVANIR Pharmaceuticals Reports First Quarter of Fiscal Year 2005 Results.
AVANIR Acquires Additional Rights to Neurodex Technology.
AVANIR Announces $17.1 Million Common Stock Offering.
AVANIR's Board of Directors Approves the Implementation of a One-for-Four Reverse Stock Split.
AVANIR Receives Approximately $4.2 Million from Exercise of Warrants.
AVANIR Pharmaceuticals Reports First Quarter of Fiscal Year 2006 Results.
AVANIR Completes $15 Million Sale of Common Stock.
AVANIR Pharmaceuticals Provides First Quarter Business Update.
AVANIR Pharmaceuticals Reports Second Quarter Fiscal 2007 Financial Results.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles